Investors Recent News Jan 23, 2020 Leap Therapeutics Presents Updated Data at the ASCO 2020 Gastrointestinal Cancers Symposium (ASCO GI) Global Meeting Jan 07, 2020 Leap Therapeutics Announces Closing of Previously Announced Equity Financing Jan 03, 2020 Leap Therapeutics and BeiGene Announce Exclusive Option and License Agreement for DKN-01 and Leap Announces $27 Million Equity Financing View All Upcoming Events There are no upcoming events at this time. View All Past Events Sep 24, 2019 at 2:00 PM EDT Leap Therapeutics, Inc. at the Ladenburg Thalmann 2019 Healthcare Conference Sep 19 - Sep 21, 2019 2019 International Gynecologic Cancer Society Annual Global Meeting Supporting Materials Clinical Data with DKN-01 | IGCS 2019 Presentation 569.4 KB Sep 9, 2019 at 8:20 AM EDT Leap Therapeutics, Inc. at the H.C. Wainwright 2019 Global Investment Conference View All
Jan 23, 2020 Leap Therapeutics Presents Updated Data at the ASCO 2020 Gastrointestinal Cancers Symposium (ASCO GI) Global Meeting
Jan 03, 2020 Leap Therapeutics and BeiGene Announce Exclusive Option and License Agreement for DKN-01 and Leap Announces $27 Million Equity Financing
Sep 24, 2019 at 2:00 PM EDT Leap Therapeutics, Inc. at the Ladenburg Thalmann 2019 Healthcare Conference
Sep 19 - Sep 21, 2019 2019 International Gynecologic Cancer Society Annual Global Meeting Supporting Materials Clinical Data with DKN-01 | IGCS 2019 Presentation 569.4 KB
Sep 9, 2019 at 8:20 AM EDT Leap Therapeutics, Inc. at the H.C. Wainwright 2019 Global Investment Conference
